Description: Model runtime is a common challenge for actuaries in the life and annuity space. In particular, applications such as pricing and forecasting may require the use of nested-stochastic calculations, which may require extensive computing resources or use of rough approximations. There are also other areas where runtime may be a challenge, such as projecting certain reserves or layering solving algorithms within actuarial calculations. Recently, runtime challenges have been exacerbated by the development of increasingly complex insurance products and changes in reporting frameworks, such as IFRS 17, LDTI, PBR, and Solvency II. Many approaches have been explored by actuaries in the past to address model runtime challenges. To further this research, the SOA has recently published the paper Predictive Analytics and Machine Learning - Practical Applications for Actuarial Modeling. The authors of the paper will share their insights on innovative techniques using the implementation of artificial intelligence and machine learning (AIML). Come examine an introduction into AIML, review how AIML can be used to circumvent nested stochastic and other runtime challenges, explore case studies, review how costs and benefits can be measured and discuss model risk management considerations. Key learning objectives include: - Understanding the fundamental concepts of AIM - Understanding applications of AIML for actuarial modeling - Learning about the costs and benefits - Learning how AIML can be applied in practice to improve model runtime

Description: As insurers search for ways to optimize the value of their actuaries, cloud-based data architecture has emerged as a leading solution to deliver quality data that enables the unlocking of actuarial potential. Hear an introduction to cloud based data architecture, explore cloud-based data strategies and view a live demo. Learn about different data “zones”, piping data between the zones, transforming data, and a collection of cloud-based tools that could be used for each one of these steps.

Description: This session will share insights on how to effectively evaluate and price the management high-cost claimants from three views: clinical, payer, and provider. Can predictive analytics help with underwriting? What are effective clinical mitigation strategies? Can VBC arrangements be used to reduce total cost of care, and how can that be priced in?

Description: The session will highlight trends in recent industry mortality and lapse studies that have been conducted, including areas where individual companies typically have limited data. The sources of data feature SOA studies as well as other industry studies conducted by consultants and/or reinsurers. Gain an understanding of current drivers of mortality and lapse experience for life insurance evidenced in industry studies, and an understanding of available data to supplement experience in areas where you may have limited internal experience.

Description: Insurance carriers today must balance a multitude of factors to remain relevant and innovate- -process improvements and efficiency (automated or traditional); -customer experience (less intrusive, more data); -distribution (aging traditional, product focus, emerging opportunities); and -mortality. While these factors are not new, true innovation in these areas require a convergence of engagement among actuaries, underwriters and data scientists to determine the specific pain points and appreciate both the benefits and consequences of various paths. Explore examples of how best to approach these topics, engage different disciplines, avoid pitfalls and ensure a holistic view. Real life examples and lessons learned will be shared during this session.

Description: The expanded use of predictive models, algorithms, and external consumer data has drawn the attention of the life insurance industry to the matter of fairness and bias in underwriting, including proposed regulation in states like Colorado and New York and a draft NAIC Model Bulletin. Insurers will benefit taking a proactive approach to verifying that their practices, both current and future, do not result in unfair discrimination. This session will help attendees in understanding potential requirements and reporting insurers must address, techniques and tools for evaluating bias, and challenges in doing so. At the conclusion of the session, attendees will be able to: - Understand proposed regulation and practices regarding fairness and bias - Identify tools and techniques for evaluating bias in their processes - Discuss the challenges the industry will face in addressing fairness in underwriting

Description: Session 3A: State-Specific Enrollment Modeling - Understanding Disenrollment Trends and Population Dynamics

Description: Virtual - Session 3A: But We have ChatGPT at home... Or Operationalizing Generative AI

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: In this session, actuaries and data scientists will describe how the Cleveland Clinic has utilized large language models to support caregivers with difficult end of life conversations with patients and their loved ones. While artificial intelligence is often prefaced with words of caution, it can also be harnessed for good.